Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pradefovir in chronic hepatitis B
NCT04543565Phase 3Unknown
- Sponsor
- Xi'an Xintong Pharmaceutical Research Co., Ltd.
- Start
- Sep 2020
- Primary completion
- Oct 2022
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pradefovir in Chronic Hepatitis B (CHB), sponsored by Xi'an Xintong Pharmaceutical Research Co., Ltd.. Status: unknown.
02
Drugs
pradefovir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT04543565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04543565.